Z-0844-2021 Class II Terminated

Recalled by Ortho Clinical Diagnostics Inc — Raritan, NJ

FDA device recall Z-0844-2021 was initiated by Ortho Clinical Diagnostics Inc on Dec 15, 2020 and is designated Class II. Reason for recall: Eltrombopag Interference for VITROS Chemistry Products TP Slides and VITROS XT Chemistry Products ALB-TP Slides The recall status is terminated (terminated Jul 27, 2021). Affected quantity: US= 223,788 ; OUS:=168,120 Totlal: 491,908.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Dec 15, 2020
Termination Date
Jul 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
US= 223,788 ; OUS:=168,120 Totlal: 491,908

Product description

VITROS Chemistry Products TP Slides- IVD measure total protein (TP) concentration in serum and plasma using VITROS 250/350/5,1 FS/4600/XT 3400 Chemistry Systems and the VITROS 5600/XT 7600 Integrated Systems Product Code: 8392292

Reason for recall

Eltrombopag Interference for VITROS Chemistry Products TP Slides and VITROS XT Chemistry Products ALB-TP Slides

Distribution pattern

Worldwide distribution - US Nationwide distribution and the countries of AR, AU, BM, BR, CA, CL, CN, CO, CR, DO, EC, FR, FR, GT, HT, IN, JP, MX, PA, PE, PR, PY, SV.

Code information

All Current, Future and Past Lots UDI: 10758750004850

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0844-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0844-2021. Report a data issue: hello@regdatalab.com.